Delivery Order SPE2DR25D2014-SPE2DR26FZ70F
- Not listed
- The Defense Logistics Agency awarded a $13,811.09 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Twinrix vaccine in syringe format. This is a firm fixed-price contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of October 21, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, valued at $19,778.01 under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which represents one of numerous pharmaceutical...
- The Defense Logistics Agency awarded a $11,068.93 delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with an ultimate completion date of September 17, 2025. This contract represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $1,455.70 with a completion date of September 10, 2025. This contract is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitive procurement through open competition, consistent with AmerisourceBergen's established track record as a primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,810.95 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This is a firm fixed price contract with an ultimate completion date of August 19, 2025, and represents a non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $31,972.39 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This firm fixed price, competitively awarded contract was issued on October 21, 2025, with an ultimate completion date of October 22, 2025. The deliverables will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $231,318.37 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. The contract is firm fixed price with an ultimate completion date of August 27, 2025, and was awarded on August 26, 2025. This delivery order carries no set-aside designation and represents a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.19 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form, valued at $4,428.38. The contract is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and was competitively awarded without set-aside designation. Performance will be conducted at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $1,761.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form, with a completion deadline of November 4, 2025. The contract, issued on November 3, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ70FDelivery Order
The Defense Logistics Agency awarded a $12,530.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, with an ultimate completion date of November 17, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare systems and enables the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's established track record as a critical pharmaceutical distributor for federal medical procurement, combined with its demonstrated capability to fulfill diverse medical supply needs through competitive contracting, positions the company as a key vendor supporting Defense Health Agency and other government healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 11/14/25 |